All
Results: 53269-53280 of 67595

Submission of Leqembi® (lecanemab-irmb) sBLA for IV maintenance dosing for the treatment of early Alzheimer's disease to the U.S. FDA completed

2024 Kaohsiung Smart City Summit & Expo Showcases Latest Digital and Net-Zero Transformation Technologies







